Lost in translation: the gap between what we know and what we do about cardiovascular

被引：6
作者：
Chow, Clara K. [1 ,2 ]
Rodgers, Anthony [1 ]
机构：
[1] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia
[2] Westmead Hosp, Sydney, NSW, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2016年 / 204卷 / 08期
基金：
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词：
DISEASE; PREVENTION; PROGRAM; HEALTH; RISK; CARE;
D O I：
10.5694/mja16.00190
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：291 / +
页数：3
相关论文
共 11 条
[1]   Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia [J].
Banks, Emily ;
Crouch, Simon R. ;
Korda, Rosemary J. ;
Stavreski, Bill ;
Page, Karen ;
Thurber, Katherine A. ;
Grenfell, Robert .
MEDICAL JOURNAL OF AUSTRALIA, 2016, 204 (08) :320.e1-320.e8
[2]   Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention A Scientific Statement From the American Heart Association [J].
Burke, Lora E. ;
Ma, Jun ;
Azar, Kristen M. J. ;
Bennett, Gary G. ;
Peterson, Eric D. ;
Zheng, Yaguang ;
Riley, William ;
Stephens, Janna ;
Shah, Svati H. ;
Suffoletto, Brian ;
Turan, Tanya N. ;
Spring, Bonnie ;
Steinberger, Julia ;
Quinn, Charlene C. .
CIRCULATION, 2015, 132 (12) :1157-1213
[3]   Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis [J].
Ettehad, Dena ;
Emdin, Connor A. ;
Kiran, Amit ;
Anderson, Simon G. ;
Callender, Thomas ;
Emberson, Jonathan ;
Chalmers, John ;
Rodgers, Anthony ;
Rahimi, Kazem .
LANCET, 2016, 387 (10022) :957-967
[4]   What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice [J].
Finegold, Judith A. ;
Manisty, Charlotte H. ;
Goldacre, Ben ;
Barron, Anthony J. ;
Francis, Darrel P. .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (04) :464-474
[5]   The impact of co-payment increases on dispensings of government-subsidised medicines in Australia [J].
Hynd, Anna ;
Roughead, Elizabeth E. ;
Preen, David B. ;
Glover, John ;
Bulsara, Max ;
Semmens, James .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (11) :1091-1099
[6]   Effect of a Computer-Guided, Quality Improvement Program for Cardiovascular Disease Risk Management in Primary Health Care The Treatment of Cardiovascular Risk Using Electronic Decision Support Cluster-Randomized Trial [J].
Peiris, David ;
Usherwood, Tim ;
Panaretto, Kathryn ;
Harris, Mark ;
Hunt, Jennifer ;
Redfern, Julie ;
Zwar, Nicholas ;
Colagiuri, Stephen ;
Hayman, Noel ;
Lo, Serigne ;
Patel, Bindu ;
Lyford, Marilyn ;
MacMahon, Stephen ;
Neal, Bruce ;
Sullivan, David ;
Cass, Alan ;
Jackson, Rod ;
Patel, Anushka .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (01) :87-U142
[7]   Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand [J].
Redfern, Julie ;
Hyun, Karice ;
Chew, Derek P. ;
Astley, Carolyn ;
Chow, Clara ;
Aliprandi-Costa, Bernadette ;
Howell, Tegwen ;
Carr, Bridie ;
Lintern, Karen ;
Ranasinghe, Isuru ;
Nallaiah, Kellie ;
Turnbull, Fiona ;
Ferry, Cate ;
Hammett, Chris ;
Ellis, Chris J. ;
French, John ;
Brieger, David ;
Briffa, Tom .
HEART, 2014, 100 (16) :1281-1288
[8]   The crux of the matter: did the ABC's Catalyst program change statin use in Australia? [J].
Schaffer, Andrea L. ;
Buckley, Nicholas A. ;
Dobbins, Timothy A. ;
Banks, Emily ;
Pearson, Sallie-Anne .
MEDICAL JOURNAL OF AUSTRALIA, 2015, 202 (11) :591-595
[9]   Inaccurate risk perceptions contribute to treatment gaps in secondary prevention of cardiovascular disease [J].
Thakkar, J. ;
Heeley, E. L. ;
Chalmers, J. ;
Chow, C. K. .
INTERNAL MEDICINE JOURNAL, 2016, 46 (03) :339-346
[10]  
Trevena L, 2015, CASE ACTION PROPOSAL
12